Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
J Sci Med Sport ; 20(2): 190-195, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27142233

ABSTRACT

OBJECTIVES: To determine the efficacy of live-high train-low on team-sport athlete physical capacity and the time-course for adaptation. DESIGN: Pre-post parallel-groups. METHODS: Fifteen Australian footballers were matched for Yo-Yo Intermittent recovery test level 2 (Yo-YoIR2) performance and assigned to LHTL (n=7) or control (Con; n=8). LHTL spent 19 nights (3×5 nights, 1×4 nights, each block separated by 2 nights at sea level) at 3000-m simulated altitude (FIO2: 0.142). Yo-Yo IR2 was performed pre and post 5, 15, and 19 nights. A 2- and 1-km time-trial (TT) was performed pre and post intervention. Haemoglobin mass (Hbmass) was measured in LHTL after 5, 10, 15, and 19 nights. A contemporary statistical approach using effect size, confidence limits, and magnitude-based inferences was used to measure changes between groups. RESULTS: Compared to pre, Hbmass was possibly higher after 15 (3.8%, effect size (ES) 0.19, 90% confidence limits 0.05-0.33) and very likely higher after 19 nights (6.7%, 0.35, 0.10; 0.52). For Yo-Yo IR2, LHTL group change was not meaningfully different to Con after 5 nights, possibly greater after 15 (10.2%, 0.37, -0.29; 1.04), and likely greater after 19 nights (13.5%, 0.49, -0.16; 1.14). Both groups improved 2-km TT, with LHTL improvement possibly higher than CON (1.9%, 0.22, -0.18; 0.62). Only LHTL improved 1-km TT, with LHTL improvement likely greater than CON (4.6%, 0.56, -0.08; 1.04). CONCLUSIONS: Fifteen nights of LHTL was possibly effective, while 19 nights was effective at increasing Hbmass, Yo-Yo IR2 and repeated TT performance more than sea-level training.


Subject(s)
Adaptation, Physiological/physiology , Athletic Performance/physiology , Physical Education and Training/methods , Physical Fitness/physiology , Altitude , Australia , Case-Control Studies , Football , Hemoglobins/analysis , Humans , Male , Running/physiology , Young Adult
3.
Front Physiol ; 7: 502, 2016.
Article in English | MEDLINE | ID: mdl-27857693

ABSTRACT

Purpose: To determine if heavy resistance training in hypoxia (IHRT) is more effective at improving strength, power, and increasing lean mass than the same training in normoxia. Methods: A pair-matched, placebo-controlled study design included 20 resistance-trained participants assigned to IHRT (FIO2 0.143) or placebo (FIO2 0.20), (n = 10 per group). Participants were matched for strength and training. Both groups performed 20 sessions over 7 weeks either with IHRT or placebo. All participants were tested for 1RM, 20-m sprint, body composition, and countermovement jump pre-, mid-, and post-training and compared via magnitude-based inferences. Presentation of Results: Groups were not clearly different for any test at baseline. Training improved both absolute (IHRT: 13.1 ± 3.9%, effect size (ES) 0.60, placebo 9.8 ± 4.7%, ES 0.31) and relative 1RM (IHRT: 13.4 ± 5.1%, ES 0.76, placebo 9.7 ± 5.3%, ES 0.48) at mid. Similarly, at post both groups increased absolute (IHRT: 20.7 ± 7.6%, ES 0.74, placebo 14.1 ± 6.0%, ES 0.58) and relative 1RM (IHRT: 21.6 ± 8.5%, ES 1.08, placebo 13.2 ± 6.4%, ES 0.78). Importantly, the change in IHRT was greater than placebo at mid for both absolute [4.4% greater change, 90% Confidence Interval (CI) 1.0:8.0%, ES 0.21, and relative strength (5.6% greater change, 90% CI 1.0:9.4%, ES 0.31 (relative)]. There was also a greater change for IHRT at post for both absolute (7.0% greater change, 90% CI 1.3:13%, ES 0.33), and relative 1RM (9.2% greater change, 90% CI 1.6:14.9%, ES 0.49). Only IHRT increased countermovement jump peak power at Post (4.9%, ES 0.35), however the difference between IHRT and placebo was unclear (2.7, 90% CI -2.0:7.6%, ES 0.20) with no clear differences in speed or body composition throughout. Conclusion: Heavy resistance training in hypoxia is more effective than placebo for improving absolute and relative strength.

SELECTION OF CITATIONS
SEARCH DETAIL
...